Swap-ratio valuations determine how many shares of the acquiring or merged entity are issued to shareholders of the transferor company. The ratio is scrutinised by the stock exchanges, SEBI (for listed entities), the NCLT, independent directors, and — if contested — by minority shareholders. Transique delivers swap-ratio valuations that are engineered to survive every one of those review layers.
Every swap-ratio report we issue covers reasoning for selection or non-selection of Asset, Income and Market based valuation approaches, fairness-range analysis, sensitivity tables and a written rationale for the recommended ratio. Reports are signed by an IBBI-Registered Valuer and are explicitly designed for NCLT filing.
An IBBI-Registered Valuer under the Companies (Registered Valuers and Valuation) Rules 2017. For listed entities, additional SEBI-prescribed valuation disclosures apply as per SEBI Circular and NSE/BSE SOP on Scheme of Arrangements.
With heightened independence, documentation and past precedents. Related-party schemes attract higher scrutiny — we document our independence, apply the most reasonable approach, and engineer the report for minority-shareholder defensibility. An Independent fairness opinion is almost always recommended.

